TP53 mutations are detected in approximately 20–35% of post-MPN sAML9–11 (collectively termed TP53-sAML), often in association with loss of the remaining WT allele12 and multiple CNAs13. The gene discussed is TP53; the disease is myeloproliferative neoplasm.